Vulnerability in Innokasmedical Vital Signs Monitor Vc150
CVE-2020-27260
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N.
EPSS exploit prediction
EPSS: 0.004 (35.2th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 35th percentile — 35.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000
Affected products
- Innokasmedical Vital Signs Monitor Vc150
- Innokasmedical Vital Signs Monitor Vc150 Firmware
- Bigcompanysoft Software Product — versions VC150 prior to Version 1.7.15
Weakness classification (CWE)
References
- us-cert.cisa.gov/ics/advisories/icsma-21-007-01 (US Government Resource, Third Party Advisory)
Frequently asked questions
- What is CVE-2020-27260?
- CVE-2020-27260 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Improper Neutralization of Special Elements in Output Used by a Downstream Component (Injection). CVSS score: 5.3/10. Published 2021-01-08.
- How severe is CVE-2020-27260?
- Medium severity. CVSS v3 base score is 5.3 out of 10.